Brokers Offer Predictions for Organigram FY2027 Earnings

Organigram Holdings Inc. (TSE:OGI) – Stock analysts at Atb Cap Markets issued their FY2027 earnings per share estimates for shares of Organigram in a research report issued on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes forecasts that the company will earn $0.08 per share for the year. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s FY2028 earnings at $0.20 EPS.

A number of other analysts have also issued reports on OGI. ATB Capital reduced their target price on Organigram from C$5.25 to C$3.50 in a report on Tuesday, December 17th. Canaccord Genuity Group reduced their target price on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a report on Monday, December 9th.

Organigram Price Performance

OGI opened at C$1.81 on Thursday. The stock has a fifty day moving average of C$2.24 and a 200-day moving average of C$2.31. The firm has a market capitalization of C$223.61 million, a P/E ratio of -3.83, a PEG ratio of 0.42 and a beta of 1.13. Organigram has a 12-month low of C$1.80 and a 12-month high of C$3.95. The company has a quick ratio of 2.62, a current ratio of 3.36 and a debt-to-equity ratio of 3.07.

About Organigram

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.